Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan for SIADH-induced Hyponatremia in Acute Neurological Injuries
NCT02545114Terminated
- Start
- Aug 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tolvaptan in hyponatremia and syndrome of inappropriate antidiuretic hormone secretion (SIADH). Primary endpoint: Serum sodium level. Started Aug 2015; status: terminated.
02
Drugs
tolvaptan
03
Conditions
hyponatremiasyndrome of inappropriate antidiuretic hormone secretion (SIADH)
Beyond the preview
Go deeper on NCT02545114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02545114.